Tabula Rasa HealthCare to Exhibit and Present at APhA Annual Meeting and Exposition

MOORESTOWN, N.J., March 16, 2018 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC) a healthcare technology company optimizing medication safety by deploying new medication risk identification and mitigation software solutions and novel, proprietary medication decision support tools, will be participating full-force at the 2018 American Pharmacists Association (APhA) Annual meeting in Nashville, Tennessee, March 16-18, 2018.

Five poster presentations will be given by TRHC and its subsidiary company, CareKinesis, clinicians and researchers during the session “Meet the Researchers: Contributed Papers Posters Presentations”, Saturday, March 17 from 12:30 – 2:30 pm. Subject matters of the Posters include:

• Evaluation of Opioid Use Among Community-Dwelling Older Adults: The Role of CYP450-Medicated Drug Interactions – Tumpa Sarker, MHS, PharmD.
• Evaluation of Opioid Use Among Community-Dwelling Older Adults: The Role of CYP450-Medicated Drug Interactions – Tumpa Sarker, MHS, PharmD.
• Drug-Induced Phenoconversion among Community-Dwelling Older Adults Who Received a Pharmacogenic Consultation – David McGain, MA, MB, PharmD
• Detection of Genetic Polymorphisms in ALOX-5 among Community-Dwelling Older Adults Prescribed Leukotriene Receptor Antagonist Therapy for Asthma – David McGain, MA, MB, PharmD.
• Antipsychotic Use within the Program of All-inclusive Care for the Elderly (PACE) – Adriana Matos, PharmD.
• Assessment of the Effect of Bio-K+Probiotic on Antibiotic-Associated Diarrhea in Community-Dwelling Older Adults – Sabina Burkowska, PharmD.

TRHC Chairman and CEO Calvin H. Knowlton, PhD and President and Chief Business Development Officer, Orsula V. Knowlton, PharmD, co-founders of the Company, will be in attendance and available to Conference participants. 

The highlight of the Annual Meeting each year is the presentation of the Hugo H. Schaefer Award. This year, TRHC Chief Pharmacotherapy Officer Robert L. Alesiani, PharmD, BCGP is the 2018 recipient. Dr. Alesiani is receiving this award based on his outstanding contributions to the APhA, the profession of pharmacy, and society. The awards and honors program at APhA is the most comprehensive and prestigious within the profession. The press announcement of the award can be found at https://www.tabularasahealthcare.com/news/.

TRHC’s Exhibit Booth 140 will be located in the Main Exhibit Hall. Please stop by to learn more about Tabula Rasa HealthCare, its brands, its technology, its medication risk mitigation solutions and its people, who will be attending the booth each day. For more information about the Conference click on this link: APhA Annual Meeting and Exposition.

About Tabula Rasa HealthCare
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable health care organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations.  For more information, visit www.TabulaRasaHealthCare.com

Forward-Looking Statements

This press release includes forward-looking statements that we believe to be reasonable as of today’s date including statements regarding risk stratification under the new scope of work.  Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions.  These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release.  Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC,  including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 14, 2018, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.

Media Contact
Dianne Semingson                                                                             
[email protected]      
T: 215-870-0829        

Investors
Bob East or Asher Dewhurst
Westwicke Partners
443-213-0500
[email protected]